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Abstract
We present a sensitive approach to predict genes expressed selectively in specific cell types, by searching publicly
available expression data for genes with a similar expression profile to known cell-specific markers. Our method,
CellMapper, strongly outperforms previous computational algorithms to predict cell type-specific expression,
especially for rare and difficult-to-isolate cell types. Furthermore, CellMapper makes accurate predictions for human
brain cell types that have never been isolated, and can be rapidly applied to diverse cell types from many tissues.
We demonstrate a clinically relevant application to prioritize candidate genes in disease susceptibility loci identified
by GWAS.
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Background
Measuring gene expression in specific cellular subsets is
key to understanding cellular function and differenti-
ation and how these processes are disrupted during dis-
ease pathogenesis. However, there are steep technical
challenges to obtaining pure populations of many cell
types for expression profiling [1]. The human brain pro-
vides a clear example: many brain cell types display ab-
normal gene expression patterns when grown in culture
[2] and must be acutely isolated from intact brain tissue
to insure physiological relevance. Validated cell isolation
protocols in mice often require the use of transgenic
animals to label specific cell types [3–6] and are not
applicable to humans. As a result, expression data are
only available for a small fraction of the ~150 cell types
[7] of the human central nervous system and this prob-
lem is similar for many other tissues.
One promising solution has been the development of
computational methods to infer cell type-specific expres-
sion information directly from heterogeneous samples
[8–19], such as undissociated tissue. These algorithms
take advantage of the fact that the relative proportion of
cell types varies from sample to sample, making it pos-
sible to statistically deconvolve expression changes in
the underlying cell types. For many biological problems,
it is not necessary to predict the total expression level of
every gene in each cell type [8, 12–16], but rather the
relative, or differential expression: specifically, which
genes are strongly expressed in one cell type relative to
others? It is these differentially expressed genes that fre-
quently control cell differentiation, define cell-specific
phenotypes, and provide the core signature of cell iden-
tity. By focusing on identifying differentially expressed
genes, it turns a more complex model-fitting problem
into a classification problem [9], opening the door to al-
gorithms that may be more sensitive, especially for rare
and difficult-to-isolate cell types. Several machine-
learning algorithms have been developed to address this
problem [17–19], each aimed at identifying genes with a
similar expression profile to an established set of cell
type-specific markers, referred to here as “query genes.”
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However, these algorithms all require very large training
sets of both positive and negative control genes (≥10 of
each) to define any cell type. This requirement poses a
severe limitation for most biological applications, as it is
difficult to curate such a large list of established marker
genes for even well-studied cell types and impossible for
many others.
Here, we present CellMapper, an algorithm optimized
for sensitive identification of cell type-enriched genes
using as little as a single query gene. We show that Cell-
Mapper can make accurate predictions for four human
brain cell types that have never been isolated and cannot
be addressed by any other computational method. We
then apply our algorithm to a large compendium of
19,801 microarrays and identify genes specifically
expressed in 30 diverse cell types of widespread import-
ance in human biology, demonstrating that CellMapper
can be readily used for cell types from many different tis-
sues. Finally, we explore a clinically relevant application to
prioritize candidate genes in loci identified by genome-
wide association studies (GWAS). Our approach can be
applied to any transcriptionally defined cell population
using publicly available microarray data.
Results and discussion
CellMapper takes as input (1) a large set of gene ex-
pression data and (2) a query gene (or genes) specific-
ally expressed in the cell type of interest and then
estimates the probability that every other gene in the
dataset is co-expressed with the query gene (Fig. 1a).
Intuitively, CellMapper returns a gene list ranked ac-
cording to the predicted expression level within the cell
type of interest relative to others. The genes predicted
to be most specifically expressed will be at the top of
the rank list, followed by genes with decreasing levels
of enrichment.
CellMapper is designed to make accurate predictions
using as little as a single query gene, which can be se-
lected from standard cell-specific markers employed by
experimental techniques such as flow cytometry, im-
munohistochemistry, and promoter-driven conditional
mouse knock out models. An important component of
our algorithm is a filter based on singular value decom-
position (SVD), which amplifies biologically informative
signals in the expression data (Additional files 1 and 2).
SVD-based filters have found diverse applications in
biology, such as increasing sensitivity when reverse-
engineering gene regulatory networks [20, 21] and con-
trolling for population structure in GWAS [22], but
have not been explored in the context of predicting cell
type-specific expression before. In a test application to
predict tissue-enriched genes (e.g. liver, heart, brain),
we found that the CellMapper SVD filter both in-
creased sensitivity and made the final algorithm con-
sistently accurate across a range of tissues (Additional
files 3 and 4). The SVD filter is likely beneficial for
multiple reasons (discussed further in Additional file 1),
such as enhancing subtle biological signals, reducing
batch effects, and increasing robustness to bias in
dataset sample composition (Additional file 5).
As a first test of CellMapper’s performance, we com-
pared it to in silico nano-dissection [17]—the most re-
cent and sensitive machine-learning algorithm to predict
cell type-enriched genes from heterogeneous microarray
data. In silico nano-dissection was previously shown to
have good prediction accuracy for kidney podocytes
using a large set of human kidney microarray data [17]
and so we applied CellMapper to this same dataset using
a b
Fig. 1 Overview and validation of CellMapper. a Schematic of the approach. CellMapper takes as input a cell type-specific query gene (green) and
a set of gene expression data and finds genes with a similar expression profile to the query gene (e.g. “Gene C” above, yellow profile). b Performance
comparison between CellMapper and the machine learning algorithm, in silico nano-dissection [17]. CellMapper and in silico nano-dissection were
each applied to identify podocyte genes and evaluated based on the recovery of an experimentally defined set of podocyte genes [23]. In
silico nano-dissection was applied using the training set selected by Ju et al. [17] for their analysis (46 query genes and 97 negative control
genes) or a smaller training set of ten query genes and ten negative control genes (the smallest training set permitted by the algorithm, see
“Methods”). CellMapper identified the experimentally defined podocyte genes with similar precision to in silico nano-dissection at all levels of
recall, despite using only one query gene
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the query gene MAFB. We found that CellMapper iden-
tified experimentally-defined podocyte genes [23] with
similar precision to in silico nano-dissection at all levels
of recall (Fig. 1b), despite using a much smaller training
set of query genes (1 query gene for CellMapper versus
47 query genes plus 97 negative control genes for in
silico nano-dissection). This finding was consistent when
CellMapper was run using podocyte marker genes other
than MAFB as the query gene (Additional file 6). We
then repeated in silico nano-dissection with a smaller
training set of ten query genes and ten negative control
genes (the smallest training set permitted by the algo-
rithm). When using this smaller training set, we observed
a decrease in performance for in silico nano-dissection,
such that it performed noticeably worse than CellMapper
(Fig. 1b, light gray line). Thus, CellMapper achieved simi-
lar accuracy to in silico nano-dissection while requiring
substantially fewer query genes.
CellMapper is accurate for cell types that cannot be
approached by other methods
We next applied CellMapper to identify genes expressed in
four cell types of the central nervous system—GABAergic
neurons, noradrenergic neurons, serotonergic neurons, and
NG2 glia—using human microarray data from the Allen
Brain Atlas [24]. These cell types were selected because
they are relevant to human disease [25, 26], but have not
been isolated from adult humans for expression analysis
before. In addition, the relatively limited knowledge of
specific markers for these cell types makes it difficult to
apply algorithms that require a large training set, such as in
silico nano-dissection. The Brain Atlas provides a unique
opportunity to fill this gap in expression data using
CellMapper: it includes microarrays from 900 distinct sub-
regions of the adult human brain, each with varying cellular
composition, and it contains sufficient signal to differentiate
genes expressed in the major brain cell classes (neurons,
astrocytes, oligodendrocytes, and microglia) [24] and likely
other brain cell types. We applied CellMapper to
search the Brain Atlas dataset using query genes
specific to GABAergic neurons (GAD1), noradrenergic
neurons (SLC6A2), serotonergic neurons (SLC6A4), and
NG2 glia (PDGFRA). Each of these genes are standard
markers for their respective cell type, and three have been
previously used to experimentally isolate the cell type for
expression profiling in mice [3, 5, 6]. This analysis
returned between 61 and 211 genes per cell type at a false
discovery rate (FDR) of 0.01 (Additional file 7).
To evaluate the accuracy of our results, we took two
complementary approaches. In the first, we examined
CellMapper predictions for literature-defined markers
(positive controls) of each cell type, including GABAergic
neurons (GAD2, SLC6A1, SLC32A1, DLX1, and DLX2),
noradrenergic neurons (DBH, TH, MAOA, CYB561, and
ADRA2A), serotonergic neurons (FEV, TPH2, HTR1A,
SLC18A2, and GATA2), and NG2 glia (CSPG4, OLIG1,
OLIG2, and SOX10). CellMapper correctly associated all
positive control genes with the expected cell type (Fig. 2a),
while excluding markers of the other cell types. In
addition, CellMapper excluded genes known to be absent
in these cell types, such as markers for astrocytes (S100B,
GFAP, SLC1A3, FGFR3, AQP4, and GLUL), microglia
(CX3CR1, AIF1, CSF1R, FCGR1A, and TREM2), and ma-
ture oligodendrocytes (PLP1, MOBP, MBP, MAG, and
CMTM5). In the second approach, we asked whether
CellMapper predictions for each cell type were enriched
for genes associated with these cell types as measured by
expression profiling in mice [3–6], where these cells have
been experimentally isolated. We found that our predic-
tions for GABAergic neurons, noradrenergic neurons, se-
rotonergic neurons, and NG2 glia were each significantly
enriched for genes expressed by the corresponding cell
type in mice (p = 8 × 10−24, p = 3 × 10−9, p = 7 × 10−32, and
p = 5 × 10−15, respectively; Fisher’s exact test), and these
findings were consistent when CellMapper was re-applied
using truncated versions of the Allen Brain Atlas dataset
(Additional file 8, left) or an alternative brain microarray
expression compendium (Additional file 8, right).
We next attempted to apply a range of existing com-
putational methods to this problem, including in silico
nano-dissection [17], weighted gene co-expression net-
work analysis (WGCNA) [10], and three “computa-
tional deconvolution” algorithms from the CellMix [12]
R package: deconf [15], the digital sorting algorithm
(DSA) [13], and semi-supervised non-negative matrix
factorization (ssNMF) [14]. Of these, only in silico
nano-dissection was designed to predict genes expressed
selectively in difficult-to-isolate cell types (similar to Cell-
Mapper); all other algorithms can be used for this pur-
pose, but were motivated by distinct biological problems
and are not expected to perform optimally in this applica-
tion (Additional file 9). We applied each algorithm to the
Brain Atlas dataset using the same query genes as above,
except for in silico nano-dissection, which required at
least ten genes, and WGCNA, which is unsupervised and
does not accept query genes. Then we assessed how ac-
curately each algorithm identified the experimentally-
defined cell type genes in mice [3–6], as quantified by the
area under the precision-recall curve (AUPR). CellMapper
consistently outperformed all other algorithms (Fig. 2b–e),
with the other algorithms showing particularly poor per-
formance for GABAergic neurons and NG2 glia (Fig. 2b,
e). Supporting this conclusion, the other algorithms were
also unable to identify standard cell type markers for most
of these cell types (Additional file 10). One explanation for
this difficulty is that these four cell types are relatively
uncommon—comprising less than 10 % of total cells in
most regions of the brain—and thus pose a particularly
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challenging problem for computational prediction. For
comparison, all algorithms performed reasonably well for
the major brain cell classes (neurons, astrocytes, oligoden-
drocytes, and microglia), with CellMapper and in silico
nano-dissection consistently outperforming the others
(Additional file 11). Thus, CellMapper can make accurate
predictions for rare cell types that cannot be addressed by
other methods.
Application to diverse cell types
We also tested CellMapper on a large panel of additional
cell types (Additional file 12), this time extending our ana-
lysis to include non-brain cell types, with multiple repre-
sentatives of all major cell classes (neural, epithelial,
connective tissue, muscle, and hematopoietic). In order
to apply CellMapper to cell types outside the brain, we
gathered three additional large microarray datasets.
The first two are meta-analyses of gene expression in
human [27, 28], each of which integrated expression
data from a wide range of sample types—including
whole organs, purified cell populations, and cell lines.
The third is a meta-analysis of gene expression in
mouse [29] and includes microarrays from a similarly
diverse set of samples. Combined, these additional data-
sets comprise 16,090 microarray samples and contain
expression data for 20,411 genes. This large microarray
compendium covers essentially every mammalian tissue
and contains samples of most cell types in purified and/
or mixed form.
We curated one query gene for each cell type and
applied CellMapper to search the microarray datasets
using these query genes (Additional file 12). This ana-
lysis resulted in a mean of 331 cell type-enriched genes
predicted per cell type (FDR ≤ 0.01; Additional file 1).
Again, the quality of our results was evaluated using
literature-curated positive control genes (both the posi-
tive control genes and references used to select them are
described in Additional file 13) as well as a set of nega-
tive control genes, which included cell-specific markers
for non-target cell types (Additional file 13, bold genes)
and a reference set of housekeeping genes [30]. For
every cell type, CellMapper identified over half of the
positive control genes within the top 100 predictions
(Fig. 3), and excluded almost every negative control
gene. In total, 205 out of 236 positive controls were
ranked within the top 100 predictions for the correct cell
type (86.9 %) and all but six were ranked within the top
500 predictions (97.5 %). Thus, CellMapper is accurate
for both single-organ and multi-organ cell types and for
cell types difficult to isolate or culture (e.g. Schwann
cells, Paneth cells). For applications of CellMapper to
additional cell types, both the algorithm and pre-
processed microarray data are available as an R package
in Bioconductor.
Prioritizing candidate genes affecting human disease
GWAS have linked numerous human genetic variants,
such as single nucleotide polymorphisms (SNPs), to
a b c
d e
Fig. 2 Application of CellMapper to brain cell types that are difficult to address by other methods. a CellMapper was applied to the Allen Brain
Atlas dataset using the indicated query genes for four brain cell types. Dot charts display the rank of literature-defined cell-specific markers (positive
controls) within CellMapper’s predictions for each cell type. Dots are colored based on their known primary cell type of expression. Dark gray shading
covers the area (rank list) required to identify all positive control genes for each cell type. A similar analysis using query genes other than GAD1, SLC6A2,
SLC6A4, and PDGFRA for the four cell types is provided in Additional file 16. b–e Performance evaluation of CellMapper and other computational
methods to recover genes expressed in the four brain cell types. Each method was evaluated based on the recovery of an experimentally-defined
[3–6] set of cell type-enriched genes in mouse, as quantified by the area under the precision recall curve (AUPR). WGCNA returns several
modules of gene co-expression, the best performing WGCNA module is plotted for each cell type
Nelms et al. Genome Biology  (2016) 17:201 Page 4 of 13
different traits and diseases. Although each associated
variant implicates a genomic region that can include as
many as ten or more genes, only one is typically relevant
to disease pathogenesis [31]. One successful approach to
prioritize GWAS candidate genes has been to look for
genes that are selectively expressed in the tissue(s) or cell
type(s) most relevant to disease pathogenesis [32, 33].
CellMapper offers several advantages for this method of
analysis because it can profile almost any relevant cell
type, as long as one marker gene is known.
As a proof of principal, we applied CellMapper to
prioritize genes from two recent GWAS meta-analyses
of erythrocyte [34] and platelet [35] phenotypes, two
examples where high quality GWAS data are available
and the relevant cell type is unambiguous. CellMapper
predictions for erythrocytes and platelets were more
than tenfold enriched within 10 kb of SNPs associated
with red blood cell and platelet phenotypes, respectively
(p = 1.0 × 10−9, p = 6.9 × 10−5; Fisher’s exact test), pro-
viding initial evidence that CellMapper might be used
to highlight genes from these studies. Among the
GWAS loci for erythrocyte and platelet genes, we found
30 candidates predicted to be selectively expressed in
the relevant cell type (Additional file 14). One gene that
stood out was TRIM58 because it is in a locus associ-
ated with both erythrocyte and platelet cell number
(Fig. 4a) and predicted to be selectively expressed in
both cell types with high confidence (FDR < 10−15). To
test our expression prediction, we measured TRIM58
expression across hematopoietic cells by quantitative
real-time polymerase chain reaction (qRT-PCR), and
found that it was expressed exclusively in eryothrocytes,
platelets, and their common progenitors (Fig. 4b). This
result implicates a role for TRIM58 in the developmen-
tal program for erythrocytes, as just recently described
[36], and for platelets.
We next applied CellMapper to analyze GWAS re-
sults for the chronic inflammatory bowel diseases
(IBD), a complex set of diseases involving many cell
types, including some that lack gene expression pro-
files. We focused on the 163 IBD susceptibility loci
identified by Jostins, et al. [37], 38 of which lack any
candidate gene(s) highlighted by previous prioritization
strategies. Genes predicted by CellMapper to be differen-
tially expressed in T cells, B cells, NK cells, and platelets
were more than fivefold enriched among genes located
within 10 kb of IBD SNPs (p < 0.01 for all cell types),
highlighting the well-known relevance of the three
lymphocyte cell types to IBD [38] and supporting the view
that platelets also play an active role in disease pathogen-
esis [39]. We searched IBD loci for genes predicted to be
differentially expressed in these four cell types and four
others that contribute to IBD [38]—macrophages, simple
epithelial cells, goblet cells, and Paneth cells. This analysis
highlighted 64 novel candidates and provided additional
support for 75 previously implicated genes (Additional file
14). Example candidates highlighted by CellMapper are
C1orf106 and KIF21B (Fig. 4c), two genes in the same
locus predicted to be enriched in simple epithelial cells
and in T and NK cells, respectively. As before, we verified
Fig. 3 CellMapper is accurate across diverse cell types. CellMapper was applied using query genes for 30 cell types (Additional file 12); Tukey
boxplots display the rank of 4–10 literature curated markers (positive controls; Additional file 13) and ≥48 negative control genes (Additional file
13 and housekeeping genes from [30]) for each cell type, demonstrating that CellMapper sensitively identified established cell type markers in
every case. Filled circles represent the rank of all positive control genes; open gray circles represent negative control genes that fall outside 1.5
times the interquartile range of the other negative control genes (“outliers”). In only eight instances (0.5 %) was a negative control gene identified
within the top 100 predictions for a cell type. EECs enteroendocrine cells
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our expression predictions by qRT-PCR, this time using
human immune cell types isolated by FACS, cultured
endothelial and epithelial cell lines, and primary intestinal
epithelial organoids (Fig. 4d). The results confirm epithe-
lial expression of C1orf106, and T and NK cell expression
of KIF21B. This example illustrates another benefit of
CellMapper as a prioritization strategy for GWAS: Cell-
Mapper can be used to not only prioritize candidate
genes, but also to suggest which cell type(s) might be
affected for each candidate. C1orf106, the gene we discov-
ered to be epithelia-specific, is particularly interesting as
an IBD candidate because rare coding variants in this gene
have been associated with an increased risk for IBD [40].
To assess whether CellMapper could also be used to
prioritize candidates for other diseases, we comprehen-
sively searched for enrichment of disease candidate genes
among our top predictions for each of the 30 cell types.
We considered both genes linked to human genetic
disorders in Online Mendelian Inheritance in Man [41]
(OMIM) and genes in disease susceptibility loci identified
by GWAS [42]. Both OMIM genes and GWAS candidates
were significantly enriched in the top 200 predictions
across all cell types (p = 1.8 × 10−20 and 4.3 × 10−19, re-
spectively; Fisher’s exact test). Furthermore, we frequently
found that genes linked to individual diseases were
enriched in the top predictions for specific cell types
(Additional file 15) and these disease-cell type associations
primarily highlighted cell types with an established role in
disease pathology. These results demonstrate the potential
of CellMapper to prioritize genes for many other human
diseases.
Conclusions
We developed CellMapper as an approach to obtain the
gene expression profiles unique to individual cell types.
Such data are often required for continued advances in
biology and medicine. Unlike experimental methods to
define cell type-specific gene expression, CellMapper can
be rapidly applied using existing publicly available micro-
array data and knowledge of only a single cell-specific
marker gene. Markers can be used to delineate not only
individual cell lineages (DEF5A+ Paneth cells), but also
larger classes of cells with similar function (KRT8+ simple
epithelia), thus allowing the level of resolution to be tai-
lored to the needs of each specific biological question.
Furthermore, CellMapper is effective for cell types that
have never been isolated before, providing an opportunity




Fig. 4 Using CellMapper to prioritize GWAS disease genes. a The genetic locus surrounding sentinel SNP rs381144, associated with erythrocyte
(Ery) and platelet (MkP) cell number. Other relevant SNPs in the region are shown. All genes predicted for expression in erythrocytes and platelets
are displayed in red. b TRIM58 expression in primary mouse hematopoietic cells by qRT-PCR. MPP multi-potent progenitor, PreMegE pre-megakaryocyte-
erythrocyte, Ery erythrocyte, MkP megakaryocyte/platelet, GMP granulocyte-monocyte progenitor, Neu neutrophil, MΦ macrophage, cDC conventional
dendritic cell, B B cell, T T cell, NK natural killer cell. c The genetic locus surrounding sentinel SNP rs7554522, associated with inflammatory bowel disease
(IBD). Genes colored in purple are predicted for simple epithelial cells, genes colored in green are predicted for T and NK cells. d C1orf106 and KIF21B
expression in human primary cells and cell lines. Mono monocyte, HMEC1 endothelial cell line, Caco2 colon epithelial cell line, Organoid primary
epithelial organoid from small intestine biopsy. All bars are mean +/− SD (n = 3–7 independent biological replicates) and letters indicate statistically
significant differences between groups (p ≤0.05, Tukey’s honest significant difference test)
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Our results establish CellMapper as a general and ac-
curate method, and a resource for diverse applications in
biology and medicine. Not only can CellMapper identify
new cell type-specific markers, but the complete set of
genes predicted to be enriched in a cell type can be used
for many applications, such as inferring transcription
factor binding motifs [43] or identifying biological path-
ways particularly active in a given cell type. There is also
value in combining cell type-specific expression with
other sources of high throughput data in order to sug-
gest novel gene candidates for a pathway. We show this
application by integrating cell type expression with
GWAS data, but a similar approach could be applied to
other problems, such as to identify genes of a particular
class or function (e.g. membrane trafficking genes) that
are strongly expressed by a specific cell type (e.g. polarized
epithelial cells).
We found that CellMapper outperformed other compu-
tational methods and provided accurate predictions for
difficult-to-isolate cell types where the other methods
failed. This result highlights the need to develop computa-
tional tools optimized for the specific questions being
asked. For example, the three “computational deconvolu-
tion” algorithms we tested (DSA, deconf, and ssNMF)
were originally created to address problems distinct from
CellMapper: in diseases where the proportion of different
cell types varies according to disease state (e.g. cancer,
Huntington’s disease), these methods can distinguish be-
tween changes in gene expression caused by changes in
cell type frequency from those caused by altered gene ex-
pression within the individual cell types. This question is
biologically important and clinically relevant, but cannot
be addressed by CellMapper. Similarly, many algorithms
have been created to predict genes in a co-regulated
biological pathway based on co-expression analysis.
CellMapper could be applied to identify genes in a similar
biological pathway as a query gene, but we would not
expect it to compete favorably with existing algorithms
[44, 45] designed for this purpose. For the important ques-
tion of identifying which genes are most selectively
expressed in a cell type, however, CellMapper excels.
A built-in limitation of CellMapper, and related ap-
proaches, is that they depend on the availability of cell-
specific marker genes and large, representative expression
datasets. Fortunately, marker genes have been established
for a wide variety of cell types and the requirement of a
single marker gene is no greater than that needed by ex-
perimental approaches such as by FACS and immunohis-
tochemistry. The availability of expression data will be
most limiting for rare cell types that populate a single
organ, but we showed that CellMapper can still separate
genes expressed in closely related cell types such as
neuron subtypes and intestinal epithelial lineages. Another
limitation is that CellMapper has currently only been
validated for use with microarray data. Certain classes of
genes, such as long non-coding RNAs, are not well repre-
sented in most microarray platforms. Many algorithms
that explore gene co-expression relationships have trans-
lated well to RNA sequencing (RNA-Seq) data [46], and
CellMapper in principle could be adapted for RNA-Seq to
allow for more complete coverage of the transcriptome.
Methods
Dataset acquisition and processing
Four large microarray datasets were gathered for this
study, each comprising numerous microarray experiments
performed on a single Affymetrix platforrm. Two of the
datasets were downloaded from ArrayExpress (accession
numbers E-MTAB-62 and E-MTAB-27); these contain
5372 experiments on the Human Genome U133A array
[28] and 1323 on the Mouse Genome U74A array [29].
The third dataset was kindly provided by J. Engreitz, and
contains 9395 experiments on the Human Genome U133
Plus 2.0 array [27] (now available on GEO: GSE64985).
RMA-normalized expression values were adjusted to re-
duce the influence of technical bias (i.e. variation in
hybridization conditions or starting material) using the R
package bias 0.0.3 [47]. In addition, a fourth normalized
dataset was downloaded from the Allen Brain Atlas [24]
and analyzed without further processing. To generate an
intestine-specific subset of microarray data (used for the
four intestinal epithelial lineages), all samples from the
Engreitz et al. [27] dataset with the terms COLON* or
INTESTIN* in the title or abstract of the GEO submission
were included, as well as samples from the Lukk et al. [28]
dataset that were annotated by the authors as from
“colon,” “colon mucosa,” or “small intestine.” Kidney
podocytes were analyzed using the same datasets as in Ju
et al. [17] (GEO accessions: GSE32691, GSE35488,
GSE37455, GSE37460, and GSE47185).
Probesets were mapped to Entrez gene identifiers with
the Bioconductor annotation packages hgu133a.db [48]
and mgu74av2.db [49], and values for probesets mapping
to the same gene were averaged to produce a single ex-
pression measurement for each gene. Mouse Entrez gene
identifiers were then mapped to the corresponding human
orthologs using a hierarchy of orthology predictions: first,
mouse genes were mapped to human orthologs using
orthology predictions from the Mouse Genome Institute
(MGI); second, genes not mapped by MGI were then
matched to human genes with an identical HGNC name;
third, the remaining genes were mapped using orthology
predictions from Inparanoid, then Ensembl, and finally
Homologene. This hierarchical mapping strategy ensured
reasonable specificity while maintaining greater sensitivity
by using multiple orthology databases. All orthology pre-
dictions were downloaded from the HGNC Comparison
of Orthology Predictions (HCOP) database [50].
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Performance evaluation of computational algorithms
This section describes all performance evaluation to
compare between computational algorithms in the main
text. Each algorithm was tested against a gold standard
of experimentally defined cell type-enriched genes in
mice. Podocyte gold standards were from Table S1 of
Brunskill et al. [23]. Serotonergic gold standards were
from Table 1 of Dougherty et al. [5]. GABAergic neuron
gold standards were all genes with a mean expression at
least threefold higher in the GAD1+ samples from
Sugino et al. [3] than in other samples. Gold standards
for NG2 glia and the major brain cell class were all
genes with a mean expression at least threefold higher in
the purified cell type than in the other samples from
Zhang et al. [6]. Noradrenergic gold standards were all
genes from Table S2 of Grimm et al. [4] with a “Ratio
LC” greater than ten (more than tenfold higher expres-
sion in Noradrenergic neurons than the whole-brain ref-
erence) and a “Ratio LC” at least fivefold greater than
the ratio for other neuron subtypes. Gold standard genes
from mouse were then mapped to the orthologous hu-
man genes using the procedure described in the “Dataset
Acquisition and Processing” section, above.
To predict cell type-enriched genes with in silico nano-
dissection: in silico nano-dissection was applied using the
nano-dissection web server (nano.princeton.edu) and ei-
ther the “Renal Microdissections” or “Allen Brain Atlas”
datasets. For podocytes, we used the positive and negative
control training sets from the original nano-dissection
paper (47 positive and 97 negative control genes) or a
smaller training set of ten positive and ten negative con-
trol genes, which included the ten podocyte markers listed
in Additional file 13 plus MAFB as positive controls and
markers for the other major kidney cell types as negative
controls (negative controls: CDH5, KDR, and TEK for
endothelia; ACTA2, CD34, and PDGFRB for mesangial
cells; AQP1, SLC12A1, SLC12A3, and UMOD for tubule
cells). Positive controls for the brain cell types were:
GABAergic neurons (GAD1, GAD2, SLC32A1, SLC6A1,
DLX1, DLX2, ABAT, ARX, GABBR2, and NPY), noradren-
ergic neurons (SLC6A2, DBH, MAOA, CYB561, TH,
ADRA2A, SLC18A2, SLC31A1,TFAP2A, and TFAP2B), se-
rotonergic neurons (SLC6A4, SLC18A2, FEV, TPH2,
HTR1A, GATA2, GATA3, TPH1, HTR1B, and DDC), NG2
glia (PDGFRA, CSPG4, SOX10, OLIG1, OLIG2, SOX8,
SOX3, GPR17, C1QL2, and NKX2-2), neurons (L1CAM,
SYT1, NRXN1, SNAP25, SLC12A5, TUBB3, ENO2,
STMN2, SYN2, and SYN1), astrocytes (ALDH1L1, FGFR3,
GFAP, GJB6, F3, SLC1A3, AQP4, SLC1A2, GLUL, and
GJA1), oligodendrocytes (MOG, MOBP, PLP1, GJC2,
MAG, MAL, OLIG2, SOX10, MBP, and CNP), and micro-
glia (PTPRC, CX3CR1, CD68, CSF1R, AIF1, P2RY13,
FCGR1A, FCGR2B, SLC2A5, and TREM2). In the in silico
nano-dissection paper, the major brain cell types were
analyzed using training sets curated by the Human Protein
Reference Database (HPRD); we found that these HPRD
training sets resulted in extremely low AUPRs, which is
why we curated custom markers to apply nano-dissection
to the major brain cell types. As negative controls for the
four major brain cell classes, we used all markers for the
other three brain cell classes. As negative controls for the
four neural subtypes, we included markers for the other
three subtypes as well as a set of genes expressed in non-
target brain glia (ALDH1L1, SLC1A2, SLC1A3, GFAP,
GJB6, FGFR3, AQP4, GJA1, GLUL, F3, PTPRC, CX3CR1,
AIF1, CSF1R, FCGR1A, TREM2, FCGR1B, P2RY13,
SLC2A5, CD68, MOG, PLP1, MOBP, SOX10, MAG, MBP,
GJC2, OLIG2, CNP, andMAL).
To predict cell type-enriched genes with the digital
sorting algorithm (DSA), deconf, or semi-supervised non-
negative matrix factorization (ssNMF): DSA, deconf, and
ssNMF were applied to the Brain Atlas data using the
wrappers provided in the CellMix [12] R package. There
are two distinct options in the CellMix package for
ssNMF: ssKL and ssFrobenius. All reported AUPRs are for
the results obtained with ssFrobenius as this method re-
sulted in a consistently higher AUPR than ssKL.
To predict cell type-enriched genes with WGCNA:
WGCNA has been previously applied to the Allen Brain
Atlas dataset [24], and we gathered the 13 modules identi-
fied by this previous analysis (Table S4 of [24]). AUPR was
calculated for each individual module after ranking all
genes according to their module membership (the correl-
ation between each gene and the module eigengene) and
then the maximum AUPR achieved by any module was
reported.
The CellMapper algorithm
Below is a description of the CellMapper algorithm; a
more detailed discussion and rationale for the CellMapper
SVD filter is provided in Additional file 1.
Singular value decomposition (SVD) filter
Expression data (m genes × n samples) were scaled such
that each gene had a mean expression of 0 and standard
deviation of 1. The scaled expression matrix, X, was then
factored by SVD:
Xmn ¼ UmnEnn VTnn
where U and V contain the right- and left-singular
vectors of X and Σ contains the singular values of X in
decreasing order along the diagonal. These SVDs were
then used to weight results using two components. First,
singular values are scaled by an exponent, α, in order to
reduce the relative importance of the early singular vec-
tors. Alpha can fall between 1 (no scaling) and 0 (all sin-
gular values have equal weight). We investigated choices
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of α (Additional file 4) and selected α = 0.5 for all ana-
lyses described in this paper. Second, the singular values
are multiplied by a weight term that smoothly filters out
singular vectors where the query genes are not well sep-
arated from the rest of the genome:






where σk represents singular value k, α is the singular
value scaling factor, and uk
g is the loading of gene g in
singular vector k, normalized so that the mean uk is 0
with a standard deviation of 1. The rationale for our
SVD filter, and the selection of the parameter α, are de-
scribed in detail in Additional file 1. After filtering the
singular values, the data were transformed back:
Xmn ¼ UmLΣLL0VTnL
where Σ' is the transformed singular value matrix, and L
is the number of singular vectors to keep during the fil-
ter (L ≤ n). We selected L to trim singular vectors that
account for less variance than an individual sample in
the original dataset (Kaiser’s criterion), thereby removing
singular vectors that mainly account for noise.
Calculate similarity to reference expression profile
After the SVD filter is applied, we calculate the mean of









where ρgQ is the Pearson’s correlation of gene g with query
gene Q and N is the total number of query genes.
Assessing statistical significance
We first standardize the Fisher-transformed correlations
by their median and median absolute deviation (MAD):
Sg ¼ zg−median zð Þ1:4826MAD zð Þ
P values are then calculated for Sg using the standard
normal distribution; this produces equivalent results to a
permutation test, as Sg closely approximates a standard
normal distribution when sample labels are scrambled
(R2 = 0.999996 in a normal QQ plot). The SVD filter,
query-driven search, and statistical significance are
calculated separately for each microarray platform, then
p values from all three platforms for each gene are
pooled together using Stouffer’s Z-score method.
Prioritizing GWAS candidates with CellMapper
We prioritized candidate genes located near GWAS
SNPs in two phases. In the initial phase, we determined
which cell types are “priority” cell types for a particular
GWAS disease. We first searched for GWAS positional
candidates enriched in the top 200 cell type-enriched
genes from each CellMap cell type (p ≤ 0.05; Fisher’s
exact test adjusted for multiple hypothesis testing with
Holm’s method). This enrichment analysis provided an
unbiased (data-driven) picture of which cell types might
be linked to the GWAS phenotype. We used a window
of 20 kb centered around each GWAS SNP to define
GWAS positional candidates; this window prioritizes
specificity (i.e. contains the most likely candidate genes)
at the cost of sensitivity (many potential candidates will
be missed). We then examined the literature to find
other cell types frequently associated with the GWAS
disease. Any cell types highlighted by either (1) the
enrichment analysis or (2) the literature were considered
as priority cell types. The majority of “priority” cell
types for a particular GWAS were highlighted by both
approaches.
In the second phase, we searched for genes located
near GWAS SNPs that are associated with one of the
priority cell types by CellMapper. For this phase, sensi-
tivity was emphasized over specificity: we considered
any genes in linkage disequilibrium with a GWAS SNP
up to a maximum distance of 250 kb and selected all
CellMap genes with an FDR ≤ 0.1.
Experimental validation of predicted GWAS candidate gene
expression
Purified cell samples were isolated for qRT-PCR as fol-
lows: for murine immune cells, splenocytes were isolated
from C57BL/6 wild-type mice. Cells were sorted by
fluorescence-activated cell sorting (FACS) based on the
following cell surface stains: B cells, CD3− CD19+; NK
cells, CD3− CD19− NK1.1+; dendritic cells, Lin− (CD3,
CD19) CD11b+ CD11c+ F4/80−; macrophage, Lin− (CD3,
CD19) CD11b+ F4/80+; neutrophils, CD11b+ Ly6G+; T
cells, CD3+ CD19−. For other murine hematopoietic
cells, 10–14-week old C57Bl/6 mouse bone marrow cells
were isolated by crushing iliac crest bones, femurae, and
tibiae in phosphate buffered saline (PBS) containing 5 %
FCS and 2 mM EDTA. After red blood cell lysis, the
remaining cells were stained with monoclonal antibodies
and sorted by FACS as described in Pronk et al. [51].
For human immune cells, peripheral blood mononuclear
cells were isolated from leukapheresis packs using a
ficoll gradient. Cells were sorted by FACS based on the
following cell surface stains: B cells, CD3− CD19+; NK
cells, CD3− CD19− CD56+; monocytes, Lin− (CD3,
CD19) CD14+; T cells, CD3+ CD19−. For solid tissue
cells, HMEC-1 cells were obtained from Sean Colgan
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and grown in MCDB 131 (Gibco) supplemented with 10 %
fetal bovine serum (Gibco), 10 mM L-glutamine (Gibco),
10 ng/mL mouse Epidermal Growth Factor (Peprotech),
and 1 ug/mL Hydrocortisone (Sigma). Caco-2 BBe cells
were obtained from Jerry Turner (University of Chicago)
and grown in DMEM (Gibco) supplemented with 10 %
fetal bovine serum. Two weeks before lysing cells for qRT-
PCR, Caco-2 cells were plated on 0.4 um polycarbonate
Transwell inserts (Corning) and grown with media changes
three times per week. Primary epithelial organoids were
generated from endoscopic biopsy samples of normal hu-
man duodenum and cultured according to Sato et al. [52].
For qRT-PCR, RNA was extracted from the purified cell
populations using the RNeasy micro kit (Qiagen), then con-
verted to first strand complementary DNA using Super-
script III reverse transcriptase (Invitrogen). Quantitative
PCR was performed on a BioRad C1000 Thermal Cycler
with a CFX96 Real Time PCR Detection System using
SYBR Green Master Mix (Invitrogen). Fold expression
change was calculated using a variant of the 2−ΔΔCT method
for multiple reference genes [53]. We selected OAZ1 and
SUMO2 as reference genes for mouse and SUMO2 and
TBP as reference genes for human. Calibrator samples were
arbitrarily chosen as erythrocyte (Fig. 4b), organoid (Fig. 4d,
left), and T cells (Fig. 4d, right). Primer sequences were
designed using primer blast [54] and synthesized by Inte-
grated DNATechnologies (Coralville, IA, USA).
To identify differential gene expression between cell
types, we first tested which of three linear models best fit
our data. The simplest model was that there is no differ-
ence in gene expression between cell types (the Null
model). The next model was that there are gene expres-
sion differences between cell types, but not between nega-
tive control cell types (the Cell Class model). The final,
and most complex, model was that there are gene expres-
sion differences between cell types regardless of class (the
Independent Cell Type model). Negative control cell types
were defined prior to analysis and were: GMP, Neu, M,
cDC, B, T, and NK for TRIM58; T, NK, B, Mono, and
HMEC-1 for C1orf106; and B, Mono, HMEC-1, Caco2,
and Organoid for KIF21B. The simplest model was pre-
ferred unless a more complex model was a significantly
better fit to the data (p ≤ 0.05, nested ANOVA F-test). The
Cell Class model was the best fit for TRIM58 and
C1orf106 and the Independent Cell Type model was the
best fit for KIF21B. Once the model was chosen, we tested
for differences between sample groups (either Independ-
ent Cell Types or Cell Classes) using Tukey’s honest
significant difference test.
Multiple-hypothesis testing
All p values were corrected for multiple hypothesis testing.
FDR was used when our goal was to identify candidate cell
type-enriched genes, as our conclusions would not change
if a small subset of these predictions were false positives
(Benjamini–Hochberg correction). Family-wise error rate
p values were used when the results of a statistical test
were interpreted directly and any false discoveries would
alter the conclusions (Holm’s method).
Additional files
Additional file 1: Description of CellMapper algorithm development
and rationale for the SVD filter. (PDF 92 kb)
Additional file 2: Schematic of the CellMapper SVD filter and algorithm.
CellMapper first performs an SVD of the microarray expression matrix to
extract major components of variation (singular vectors). Then it re-weights
the components of variation based on their estimated relevance to the
query gene, with larger weights given to components that are tightly
correlated with the query gene (e.g. “Component 3” is highly correlated
with the query gene expression pattern and receives a large weight).
Then the microarray data are reconstructed from the components using
the estimated weights. The result of this SVD filter is to emphasize the
components of variation that most distinguish the query gene and
dampen components that are less relevant to the given query. After
the SVD filtering process, genes are ranked based on the Pearson’s
correlation of their transformed expression pattern to that of the query
gene. (PDF 22 kb)
Additional file 3: Algorithm development, part 1: Performance evaluation
of five prospective algorithms using TiGER tissue genes as a gold standard
[55], compared to the final algorithm CellMapper. Tukey boxplots show the
change in area under the precision recall curve (AUPR) for each tissue,
relative to the AUPR achieved by the best-performing prospective algorithm
for that tissue. While all five prospective algorithms performed poorly
relative to the others in several tissues, CellMapper achieved the highest
AUPR in 25 out of 30 tissues and was always within 20 % AUPR of the best
method. This analysis was for algorithm development (see Additional file 1):
the prospective algorithms were not originally developed to identify
cell type-enriched or tissue-enriched genes, but we tested them in this
application because they have been effective using 1–2 query genes in
other contexts, such as finding genes in co-regulated biological pathways
(e.g. similar GO terms). MEM multi experiment matrix [44], SPELL Serial
Patterns of Expression Levels Locator [45], GR Gene Recommender [56], MI
mutual information. (PDF 11 kb)
Additional file 4: Algorithm development, part 2: Parameter
optimization for the CellMapper SVD filter, using test searches to find
tissue-enriched genes as defined in the TiGER database [55]. a Evaluation
of the free parameter, alpha. The SVD filter incorporates a free parameter,
alpha, which allows the strength of the filter to be tuned, ranging in
value from 1 (weak filter) to 0 (strong filter). Alpha values between 1 and
0.3 led to an increase in AUPR for 25 out of 30 tissues. An intermediate
value of 0.5 was chosen for the final algorithm and this parameter was
fixed prior to all analyses presented in the main text. b Evaluation of the
query-driven weight term (QDW). The SVD filter also includes a term,
abbreviated QDW, that decreases the weight of components in which
the query genes are not well separated from the rest of the genome.
The QDW term leads to an increase in performance beyond what is
seen using the alpha scaling factor alone. ***, p < 10−4; Wilcoxon singed
rank test. In both subfigures, AUPR was plotted relative to alpha = 1 and
no query-driven weight term, which is approximately equivalent to
Pearson’s correlation (it is equal to Pearson’s correlation with the low
variance principle components filtered, see “Methods”). (PDF 20 kb)
Additional file 5: Robustness of CellMapper to bias in dataset
composition. Samples were drawn from the Lukk et al. [28] dataset in
order to intentionally increase or decrease bias in sample composition
and the effect on algorithm performance was quantified. a Sensitivity to
adding redundant samples. CellMapper was applied, with and without
the SVD filter, to search for tissue-specific genes using 500 randomly
selected samples from the total microarray dataset, plus varying numbers
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of added “redundant samples.” For this analysis, “redundant samples”
were selected from a subset of the data annotated as “blood,” “bone
marrow,” and “mammary gland” because these three sample annotations
are the most over-represented in the Lukk dataset, accounting for over
half of all samples. While performance degraded when redundant samples
were added without the SVD filter, CellMapper actually performed better
and was able to benefit from the increase in sample size. b Sensitivity to
removing relevant samples. Samples annotated as belonging to a specific
tissue were removed from the Lukk dataset and CellMapper was applied
to search this truncated dataset for genes expressed in the tissue with
samples removed. This analysis was run separately for each of seven tissues
(“bone,” “colon,” “kidney,” “liver,” “ovary,” “prostate,” and “skin”), and the
mean change in AUPR across all tissues is reported. These tissues were
analyzed because they represent an intermediate number of samples in
the Lukk dataset (50–150 samples for each tissue or 1–3 % of the total).
(PDF 19 kb)
Additional file 6: Robustness of CellMapper to query gene choice;
companion figure to Fig. 1b. To test the sensitivity of CellMapper to the
choice of query gene, we repeated our analysis for kidney podocytes
using ten distinct query genes (MAFB and the nine positive control genes
in Additional file 13) and then assessed how well each analysis recovered
an independent, experimentally-defined set of podocyte genes in mouse
[23]. This plot shows the area under the precision-recall curve (AUPR)
achieved when using each of the ten query choices. For comparison, we
included a dotted line for the AUPR achieved by in silico nano-dissection
when given all ten query genes at once (light blue dotted line; the area
under the light gray line in Fig. 1b), or when given the original training
set of 47 positive control and 97 negative control genes (dark blue dotted
line; the area under the dark gray line in Fig. 1b). All ten single query gene
searches for CellMapper resulted in a higher AUPR than in silico nano-
dissection achieved when given all ten of these genes at once. MAFB was
selected as the primary query gene for podocytes in this study (i.e. the red
line in Fig. 1b) because it was used by the Genitourinary Developmental
Molecular Anatomy Project [57] (GUDMAP) for all podocyte labeling and
isolation in their large evaluation across kidney cell types. (PDF 20 kb)
Additional file 7: CellMapper predictions for each of the 30 cell types.
(XLSX 2677 kb)
Additional file 8: Robustness of CellMapper to dataset size and
composition. CellMapper was applied to predict genes expressed in
each of the eight brain cell types, using random subsets of (left) the
Allen Brain Atlas dataset or (right) an independent expression
compendium of 1237 human brain samples drawn from the Lukk et al.
[28] and Engreitz et al. [27] datasets (the “Affymetrix Brain Samples”
compendium). The accuracy with which each search identified the
experimentally-defined cell type genes in mice [3–6] was then quantified
by the area under the precision-recall curve (AUPR). AUPR was calculated for
50 randomly sampled datasets of the indicated sample sizes and then mean
AUPR was calculated. Results are reported as a heatmap, with all AUPRs
scaled relative to the performance achieved when using the complete Allen
Brain Atlas dataset for each cell type. The sensitivity to dataset abundance
varied, with maximum AUPR being reached between 100 and 2000
microarray samples depending on the cell type. Overall, we conclude
that a high quality, large, and uniformly collected dataset such as the
Allen Brain Atlas is likely to allow for accurate predictions for a wider
range of cell types. Black squares indicate that the AUPR was not significantly
different from chance (Bonferroni corrected p value > 0.05; permutation
test). (PDF 81 kb)
Additional file 9: Brief overview of computational algorithms tested in
Fig. 2. (PDF 100 kb)
Additional file 10: Previous algorithms fail to identify established marker
genes for four neural cell types; companion figure to Fig. 2b. This figure
replicates Fig. 2a using in silico nano-dissection, DSA, and Pearson’s correla-
tion—the best performing previous algorithms. Dot charts display the rank
of classic cell-specific markers (positive controls) for the four neural cell
types, as predicted by (a) in silico nano-dissection, (b) DSA, or (c) Pearson’s
correlation. Dots are colored based on their known primary cell type of
expression. Dark gray shading covers the area (rank list) required to identify
all positive control genes for each cell type. Only CellMapper accurately
identified classic marker genes for these cell types. (PDF 55 kb)
Additional file 11: Performance evaluation of CellMapper and other
computational methods to recover genes expressed in four major brain
cell classes: neurons, astrocytes, oligodendrocytes, and microglia. Unlike
the neural cell types examined in Fig. 2 and Additional file 16, these four
cell classes are fairly common in the brain and have been successfully
analyzed by previous computational algorithms. Each method was
evaluated based on the recovery of an experimentally defined [6] set of
cell type-enriched genes in mouse, as quantified by the area under the
precision recall curve (AUPR). All methods show some resolution to
resolve genes expressed in these cell types, but the best performance
was consistently from CellMapper and in silico nano-dissection. (PDF 24 kb)
Additional file 12: Table of query genes and expression datasets used
for each cell type in this study. (PDF 97 kb)
Additional file 13: Table of positive control cell type markers selected
for Figs. 2 and 3. Five markers were chosen for each of the neuron
subtypes and intestinal epithelial subtypes, four for NG2 Glia, and ten for
every other cell type. Genes in bold were used as negative control
markers for non-target cell types in Fig. 3. (PDF 152 kb)
Additional file 14: Table of genes within GWAS loci predicted for
expression in relevant cell types, focusing on loci associated with red
blood cell phenotypes, platelet phenotypes, or inflammatory bowel
disease (IBD). (XLSX 24 kb)
Additional file 15: Human disease genes are enriched in the top
CellMapper predictions; companion figure to Fig. 4. Enrichment of genes
linked to human genetic disorders (OMIM) or human GWAS phenotypes
(NHGRI) in the top CellMapper predictions. (a, c) Overall enrichment of
human disease genes within the top CellMapper predictions across all
30 cell types, as a function of the gene rank cutoff. (b, d) Enrichment of
genes linked to an individual OMIM disorder or GWAS phenotype within
the top 200 genes predicted for a given cell type. All cell type-disease
enrichments that reached statistical significance are shown. In panel (d),
a more permissive FDR cutoff of 0.2 was selected to favor sensitivity in
identifying potentially informative disease-cell type associations. Note that
at this cutoff, one in five associations are expected to occur by chance
and any conclusions should be interpreted appropriately. Syn. syndrome,
EKVP erythrokeratodermia variabilis et progressiva, ARVD arrhythmogenic
right ventricular dysplasia, SED spondyloepiphyseal dysplasia, SCID severe
combined immunodeficiency, FCAS familial cold autoinflammatory
syndrome, CMT Charcot-Marie-Tooth disease, MADD multiple Acyl-CoA
dehydrogenase deficiency. (PDF 176 kb)
Additional file 16: Robustness of CellMapper to query gene choice;
companion figure to Fig. 2a. To test the sensitivity of CellMapper to the
choice of query gene, we repeated our analysis for the three neuron
subtypes and NG2 glia using each of the classic cell markers (positive
controls) as query genes. Dot charts display the rank of the non-query
gene classic markers within CellMapper’s predictions for each cell type.
Dots are colored based on their known primary cell type of expression.
Dark gray shading covers the area (rank list) required to identify all positive
control genes for each cell type. Genes with promoters that have been used
to drive cell-specific expression in mice (i.e. cell-specific reporter mouse
strains available from cre.jax.org) are highlighted in bold with an asterisk
under the “Query Gene” column. These genes have well-established
expression patterns in the selected cell type and generally performed
well as query genes. Many of the other classic cell markers have alternative
sites of expression and were less effective as query genes. For instance,
SLC18A2 is expressed strongly in both serotonergic and noradrenergic
neurons and returned markers expressed in both cell types. Factors to
consider when choosing query genes for other cell types are described
in the CellMapper R Package vignette (http://bioconductor.org/packages/
CellMapper/). (PDF 69 kb)
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